CAS 31008-18-1: (1S,3aR,4S,6aR)-1-(3,4-dimethoxyphenyl)-4-(3,4,5-trimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan

Magnolin CRS

magnolin

Magnolin

Oxygen-heterocyclic compound

Magnolin is a bioactive compound, which is a lignan isolated from the plant Magnolia officinalis. It functions as a natural product with various modes of action, primarily interacting with multiple signaling pathways in biological systems. Magnolin primarily inhibits the phosphorylation of key proteins involved in processes such as inflammation and cancer cell proliferation. The current research into Magnolin has highlighted its potential applications in the biomedical field, particularly in the development of anti-inflammatory and anticancer therapies. By regulating critical pathways, Magnolin can reduce the expression of pro-inflammatory cytokines and interfere with the growth cycle of tumor cells. Additionally, its antioxidant properties are of interest in neuroprotective research, suggesting potential benefits in treating neurodegenerative diseases. Such applications make Magnolin a significant focus of study for its therapeutic potential. Scientists are actively investigating its role and efficacy, aiming to better understand its medicinal properties and uncover its full range of biological activities.

Magnolin reduces the renal oxidative stress, suppresses caspase-3 activity, and increases Bcl-2 expression in vivo and in vitro.